BTSG
BrightSpring Health Services, Inc. Common Stock (BTSG) SWOT Analysis Analysis (2026)
Strengths
ROIC of 8.9% indicates BTSG is generating acceptable capital returns, but peers with stronger asset-light models typically compound value more efficiently over time.
A cash conversion cycle of 18.2 days supports working-capital discipline, which is structurally better than peers with longer inventory and receivables cycles.
Moderate liquidity, with a 1.59 current ratio and 1.22 quick ratio, reduces near-term funding pressure versus more levered peers.
The business appears to convert invested capital into earnings reasonably well, but the absence of margin data limits evidence of a durable operating advantage versus peers.
Weaknesses
Net debt to EBITDA of 2.88x leaves BTSG more financially constrained than lower-leverage peers, which can limit flexibility in downturns.
Debt to equity of 1.17x suggests a meaningfully levered balance sheet, making BTSG structurally weaker than peers with more conservative capital structures.
Liquidity is adequate rather than strong, because current and quick ratios above 1.0 still trail the cushion typically seen in best-positioned peers.
The lack of disclosed margin metrics in the provided data makes it harder to evidence pricing power, which weakens relative positioning versus peers.
Opportunities
Improving capital efficiency from the current 8.9% ROIC could lift relative positioning if BTSG sustains returns above its cost of capital versus peers.
Further shortening the 18.2-day cash conversion cycle would free cash for growth and strengthen working-capital efficiency relative to peers.
If management reduces leverage from 2.88x net debt to EBITDA, BTSG could narrow the balance-sheet gap versus more conservatively financed competitors.
Additional disclosure or improvement in margin performance would clarify whether BTSG can convert operational scale into peer-leading profitability.
Threats
Higher leverage than many peers increases sensitivity to rate and refinancing conditions, which can pressure equity value if operating performance softens.
Because liquidity is only moderate, any working-capital shock could constrain BTSG more than peers with larger cash buffers.
If peers sustain higher ROIC or stronger margins, BTSG risks relative underperformance in capital allocation and valuation over the next 2–5 years.
Limited margin transparency in the provided data raises the risk that underlying profitability is weaker than peers, which would cap structural competitiveness.
Overall Score
BTSG appears to have acceptable capital efficiency and working-capital discipline, but its leveraged balance sheet and limited evidence of margin leadership keep peer-relative positioning only moderate.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on BrightSpring Health Services, Inc. Common Stock. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

